Solara Active Pharma Sciences Limited announced the receipt of ₹93.72 Lakhs related to the first call on 71,402 partly paid-up Rights Equity Shares. This follows the Second Reminder Notice issued on February 4, 2026, for the payment of ₹131.25 per share on 2,37,209 outstanding partly paid-up equity shares, which were initially allotted on June 19, 2024. These shares have a face value of ₹10 each, with ₹3.50 already paid-up. The original Letter of Offer was dated May 9, 2024. The ISIN numbers for these shares are also provided in the announcement. The call money mentioned is for the 'First Call'. The second reminder notice was issued on February 4, 2026. The rights issue was allotted on June 19, 2024. The letter of offer was dated May 9, 2024. The circular resolution was passed on March 4, 2026. Following the receipt of funds, the Rights Issue Committee approved the conversion of these 71,402 partly paid-up equity shares. These shares will now have a face value of ₹10 each with ₹7 paid-up. The ISIN for the converted shares is IN9624Z01022. Post-conversion, the company's paid-up capital has increased to ₹44,51,39,030.50, divided into 3,61,72,807 fully paid-up equity shares (ISIN INE624Z01016), 1,18,32,948 partly paid-up Rights Equity Shares with ₹7 paid-up (ISIN IN9624Z01022), and 1,65,807 partly paid-up Rights Equity Shares with ₹3.50 paid-up (ISIN IN9624Z01014). The company will undertake necessary corporate actions to obtain listing and trading approvals for the Converted Rights Equity Shares.
